Breakthrough Prostate Cancer Animal Study Presented at International Oncology Conference

Oct 14
08:06

2011

Dr. Isaac Eliaz

Dr. Isaac Eliaz

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

A new pre-clinical study conducted by researchers at the Indiana University Health Methodist Research Institute confirms the dramatic effects of one particular natural formula against aggressive prostate cancer tumors.

mediaimage
One out of every six men in this country is struggling with prostate cancer,Breakthrough Prostate Cancer Animal Study Presented at International Oncology Conference Articles and wading through your various treatment options can be confusing. Many factors come into play in your fight against prostate cancer—and being familiar with the latest in prostate cancer research is the best way to ensure that you’re making the right decisions for your health. A new pre-clinical study conducted by researchers at the Indiana University Health Methodist Research Institute confirms the dramatic effects of one particular natural formula against aggressive prostate cancer tumors. The study was conducted on laboratory animals using a human prostate cancer xenograft model, which I have outlined below. Lead Investigator Dr. Daniel Sliva presented the latest results of this study to hundreds of researchers and medical doctors in Rhodes, Greece, during the 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine, where I also presented on the role of Integrative Medicine and Modified Citrus Pectin in cancer treatment. In his presentation, Dr. Sliva shared the results of this in vivo (live animal) study, demonstrating the significant effects of the formula in suppressing the proliferation and metastasis of human hormone refractory (androgen independent) prostate cancer cells. In addition, the toxicology analysis proved that this formula is non-toxic and poses no risk of side effects. Dr. Sliva says “dietary supplements are used as alternative or adjuvant therapies, but rigorous scientific verification of their biological activity in vitro and in vivo is necessary for the acceptance of dietary supplements in conventional cancer treatment and prevention.” This study is significant because hormone refractory prostate cancer (androgen independent) is especially hard to treat. It’s the more aggressive, advanced form of prostate cancer that often leads to metastasis and progression of the cancer. Formulated with Natural Ingredients Proven to Support Prostate This all-natural formula I personally designed and recommend to my patients, combines botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms, and antioxidants. Ingredients were selected based on scientific research demonstrating their abilities to fight prostate abnormalities and provide broad spectrum prostate support. Formula Inhibits Tumor Growth and Genes Related to Metastasis Results of the study show that the oral administration of this formula produced a statistically significant suppression of tumor growth, compared to controls. The study was performed using a xenograft model of human prostate cancer in mice. A xenograft model is when tissue or organs from an individual of one species are transplanted or grafted onto an organism of another species, genus, or family. So highly aggressive human prostate cancer cells (tissue) are grafted onto a laboratory animal, which in this case were mice. In addition to a significant reduction in tumor volume, results of this study showed the formula also worked to inhibit a number of genes involved in cancer proliferation and metastasis. Two interesting genes that were suppressed relate to the metastatic potential and can point out to the ability of this preparation to not only inhibit the primary tumor growth, but also the metastatic process, an even more important benefit in the fight against aggressive prostate cancer. Study Further Validates Previous In-Vitro Results This formula has previously been studied at research laboratories at Columbia University, NY, NY and at the Cancer Research Laboratory, Methodist Research Institute, Indiana University Health, Indianapolis, IN, using in vitro methods (i.e. cell culture studies) and gene expression analysis. These prior studies showed significant results in this formula’s ability to inhibit prostate cancer growth and proliferation. This present study is a milestone in the research of this formula, because it used a laboratory animal model to test for toxicity and showed how the formula suppressed human prostate cancer tumor growth within a living mammal. Dr. Sliva concluded that this dietary supplement is a natural compound for the therapy of prostate cancer. Ongoing research on this formula in prostate cancer models continues to show encouraging results, and additional studies are forthcoming. For more information about this groundbreaking study and other beneficial herbs, nutrients and botanicals for prostate health, visit www.dreliaz.org.